GSK (NYSE: GSK) Settles Two California Lawsuits Over Heartburn Drug Zantac
On Wednesday, GSK (NYSE: GSK), the British drugmaker, said it had agreed to settle two lawsuits in California that claimed […]
GSK (NYSE: GSK) Settles Two California Lawsuits Over Heartburn Drug Zantac Read More »
